Skip to content

Randomised, relative bioavailability clinical trial of amylmetacresol, dichlorobenzyl alcohol, lidocaine and vitamin c lozenges after a single oral dose administration to healthy volunteers under fasting conditions in a crossover design.

Status
Completed
Phases
Phase 1
Study type
Interventional
Source
EU CTIS
Registry ID
CTIS2023-507599-34-00
Acronym
G23-00
Enrollment
60
Registered
2023-12-04
Start date
2024-03-11
Completion date
2024-04-15
Last updated
2024-03-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

healthy volunteer

Interventions

None listed

Sponsors

Geiser Pharma S.L.
Lead SponsorINDUSTRY

Eligibility

Sex/Gender
All
Age
18 Years to 64 Years

Countries

Spain

Outcome results

None listed

Source: EU CTIS · Data processed: Feb 4, 2026